Dalton Investments’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Dalton Investments’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-15,551	Closed	-$1.81M	–	46
2019 Q4	$1.81M	Sell	15,551 -16,500	-51%	-$1.91M	1.11%	25
2019 Q3	$3.67M	Sell	32,051 -61,800	-66%	-$6.14M	2.32%	11
2019 Q2	$8.94M	Sell	93,851 -20,000	-18%	-$1.88M	4.06%	8
2019 Q1	$10.4M	Buy	113,851 +38,500	+51%	+$3.15M	4.54%	7
2018 Q4	$5.72M	Buy	75,351 +20,800	+38%	+$1.53M	3.08%	10
2018 Q3	$4.36M	Buy	+54,551	New	+$5.08M	2.04%	16

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

SGCM

Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dalton Investments's CBPO Position: Q1 2020 in Review

Dalton Investments sold out of China Biologic Products Holdings, Inc. (CBPO) in Q1 2020, closing a stake of 15,551 shares — an estimated $1.81M sold.

Dalton Investments first reported a position in CBPO in Q3 2018 and held it in 6 quarters. The position peaked at $10.4M in Q1 2019. 84 funds tracked by Wall St. Rank hold CBPO as of Q1 2020.

Dalton Investments reported no remaining China Biologic Products Holdings, Inc. position as of Q1 2020 after selling out during the quarter.
Dalton Investments sold 15,551 China Biologic Products Holdings, Inc. shares in Q1 2020, an estimated $1.81M.
Dalton Investments first reported a position in China Biologic Products Holdings, Inc. in Q3 2018 and held it in 6 quarters.
Dalton Investments's China Biologic Products Holdings, Inc. position peaked at $10.4M in Q1 2019.
84 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q1 2020.

Based on Dalton Investments's 13F filing for Q1 2020, filed 14 May 2020.